Glomus Tumour

184
GLOMUS TUMOUR Dr Vineeth G Junior Resident Department of ENT Government Medical college Kottayam

Transcript of Glomus Tumour

Page 1: Glomus Tumour

GLOMUS TUMOUR Dr Vineeth G

Junior Resident Department of ENT

Government Medical college Kottayam

Page 2: Glomus Tumour

Introduction

It is the commonest benign tumour of middle

ear.

It is BENIGN, SLOW GROWING,

HYPERVASCULAR tumour.

It is so named because of its origin from

glomus bodies found over jugular bulb &

promontory.

It also contains paraganglionic cells.

Page 3: Glomus Tumour

05/02/2023

• Paraganglia cells are derived from the neural crest• Term Paraganglion first used by histologist-Kohn• Tumors of these paraganglia are divided into 2 groups:

(1)adrenal paragangliomas (90%)known as pheochromocytomas and (2) extra-adrenal paragangliomas(10%) located in the abdomen, chest,head and neck regions

Page 4: Glomus Tumour

05/02/2023

Head and neck paragangliomas are classified based on anatomic location and include the carotid body, jugulotympanic, vagal,laryngeal,nasal and orbital paragangliomas.

Page 5: Glomus Tumour

05/02/2023

Histologically, they resemble carotid body.

In middle ear paraganglia are distributed over –

1. Promontory – Along the branches of tympanic branch of

glossopharyngeal Nerve(jacobson’s nerve). or auricular br. Of

vagus(Arnold’s Nerve)

2. Dome of jugular bulb – Adventitial layer

Page 6: Glomus Tumour

05/02/2023

Glomus tympanicum tumor

Page 7: Glomus Tumour

05/02/2023

Glomus Jugulare Tumor-Arise from the dome of jugular bulb

Page 8: Glomus Tumour

05/02/2023

Page 9: Glomus Tumour

05/02/2023

SYNONYMS

Chemodectoma

Nonchromaffin paraganglioma

Ganglia Tympanica

Vascular tumour of middle ear

Page 10: Glomus Tumour

05/02/2023

• The term chemodectoma should basically be reserved for tumours that originate from the chemoreceptor system.

• The paraganglia in the temporal bone do not belong to this histological entity, in contrast with those in the carotid sinus.

• Less appropriate for lesions in the jugular foramen and in other parts of the temporal bone

Page 11: Glomus Tumour

05/02/2023

• The term glomus tumour is not an accurate term either, because the word glomus means a small circumscribed histological structure in which arterioles connect directly with veins.

• Its is due to the belief that the chief cells derived from specialised pericytes similar to true cutaneous arteriovenous(glomus) anastamosis tumours.

• But these tumours are unrelated to paragangliomas.

Page 12: Glomus Tumour

05/02/2023

• Extra adrenal paraganglion do not stain with chromium salts-Non chromaffin paragangliomas.

Page 13: Glomus Tumour

05/02/2023

HISTORY

1840 -Valentine described it first as Ganglia Tympanica.

1879-Robert weir described two cases of intratympanic

vascular tumours with pulsating intact tympanic

membrane

1902 -Guild found similarities between these tumour &

carotid body & coined the term Glomus Jugulare.

Page 14: Glomus Tumour

05/02/2023

1924 - Mason was first to describe Glomus tumours as

hyperplastic glomus bodies.

1945 -Rosenwasser was first to diagnose a patient with

glomus tumour & it’s surgical excision.

1960- Alford and Guilford classified into Glomus

Tympanicum and Glomus jugulare

Page 15: Glomus Tumour

05/02/2023

Page 16: Glomus Tumour

16

Page 17: Glomus Tumour

05/02/2023

EPIDEMOLOGY

Annual incidence of 1 case per 1.3 million people

5 times more common in female.Autosomal Dominant inheritance.Gene responsible is located on chromosome – 11q23 Age – Most commonly seen in 5th decade of life (30 and 60

years)

Commonly affected ear - LEFT

Page 18: Glomus Tumour

05/02/2023

• Glomus tumors are the most common tumor of the middle ear • Second to vestibular schwannoma as the

most common tumor of the temporal bone.

Page 19: Glomus Tumour

05/02/2023

RULE OF 10

10 % Multicentric

10 % Familial

10 % Functional

Page 20: Glomus Tumour

05/02/2023

ETIOLOGY• 40% paraganglioma heritableClassification Paraganglioma syndrome 1-4 (SDHx Mutation) Familial Phaeochromacytoma Associated with neuroendocrine syndromes-NF-1, VHL,

MEN-IIRisk for malignancyMultifocal ParagangliomaDevelop early in life

Page 21: Glomus Tumour

05/02/2023

PATHOGENESIS

Benign, Encapsulated, Slow growing, Highly

vascular, Locally invasive tumour that erodes bone.

Expand within temporal bone via pathways of least

resistance – air cells , vascular lumens , skull Base

foramina & the eustachian tube.

Page 22: Glomus Tumour

05/02/2023

The middle ear ossicles are commonly spared.

Intracranial & extracranial extension occur.

Metastases from glomus tumors occur in approximately

4% of cases. - Lung, Lymph nodes, Liver, Vertebrae, Ribs,

and Spleen

Page 23: Glomus Tumour

05/02/2023

HISTOPATHOLOGY

Macroscopically – Deep red firm mass that bleeds

profusely on touch.

Microscopically – Clusters of Chief cells arranged

in nested pattern called ZELLBALLEN enclosed by

fibrous stroma with rich vascular plexus.

Page 24: Glomus Tumour

HIST ZELLBALLEN OLOGY

Ball of cells-German zellballen pattern -which nests of chief cells (type I) are surrounded by sustenacular cells (type II or supporting cells) in a highly vascular stroma.

Page 25: Glomus Tumour

05/02/2023

• Guild classified glomus tumors into two types depending on the amount of cellular and stromal components:1. Cellular glomus bodies - when the cellular component is predominant2. Vascular glomus bodies - when the vascular stromal component predominates.

Page 26: Glomus Tumour

26

Spread of tumor • These tumors tend to expand within the temporal bone via the

pathways of least resistance, most important being pneumatized air cell tracts of temporal bone esp peritubal cells.

• They also invade and erode bone in a lobular fashion, but they often spare the ossicular chain.

Page 27: Glomus Tumour

27

• Anteriorly – via eustachian tube to nasopharynx• Inferiorly – via lumens of I J V & sigmoid sinus. via carotid sheath to neck• Laterally – middle ear & E A C • Medially – labyrinth • Intracranial spread – via hypotympanum & protympanum.

Page 28: Glomus Tumour

28

Page 29: Glomus Tumour

29

• Initially, the skull base erodes in the region of the jugular fossa and posteroinferior petrous bone, with subsequent extension to the mastoid and adjacent occipital bone.

• Significant intracranial and extracranial extension may occur, as well as extension within the sigmoid and inferior petrosal sinuses.

• Neural infiltration is also common.

Page 30: Glomus Tumour

30

Clinical features

• The diagnosis of glomus tumors is often difficult because the presenting signs and symptoms can be nonspecific, mimicking other otologic and neurologic conditions.

• Average delay in diagnosis – 6 years

Page 31: Glomus Tumour

31

• By history, patients with glomus tumors typically present with pulsatile tinnitus(80%), followed by the development of hearing loss(60%).

• The hearing loss is usually conductive because the middle ear is filled with tumor, although a sensorineural hearing loss may develop if the cochlea is invaded.

Page 32: Glomus Tumour

32

• Other aural signs and symptoms are ear fullness, otorrhea, hemorrhage, bruit, and the presence of a middle ear mass.

• Ear pain is uncommon.

• Involvement of the inner ear produces vertigo and sensorineural hearing loss.

Page 33: Glomus Tumour

33

s

Page 34: Glomus Tumour

34

• Patients with glomus tympanicum tumors present with smaller tumors because the middle ear becomes involved earlier than with glomus vagale or jugulare tumors.

• On the other hand, patients with glomus jugulare tumors may present with dysfunction of jugular foramen contents

Page 35: Glomus Tumour

35

• In clinical practice, perhaps the most common is Vernet's syndrome (named after the French neurologist Maurice Vernet).

• This syndrome comprises paralysis of the cranial nerves IX, X and XI.

Page 36: Glomus Tumour

36

• In rare cases, a thrombosed sigmoid-jugular complex may give rise to retrograde thrombosis of the inferior petrosal sinus and eventually even to thrombosis of the cavernous sinus.

• This condition then leads to the cavernous sinus syndrome, i.e. paralysis of cranial nerves III, IV and VI, oedema of the conjunctiva and upper eye lid, venous congestion in the fundus of the globe and proptosis.

Page 37: Glomus Tumour

37

• Blockage of the cerebral venous drainage through the jugular foramen can also cause increased intracranial pressure and give rise to epileptic seizures.

Page 38: Glomus Tumour

38

• The presence of jugular foramen syndrome (paresis of cranial nerves IX-XI) is pathognomonic for this tumor, but it usually follows one year after the initial symptoms of hearing loss and pulsatile tinnitus.

• Less commonly, glomus tumors produce facial nerve palsy, hypoglossal nerve palsy, or Horner syndrome.

Page 39: Glomus Tumour

39

• Headache, hydrocephalus, and elevated intracranial pressure may be produced by intracranial extension of the tumor.

• Ataxia and brainstem symptoms may also develop.

Page 40: Glomus Tumour

40

• In about 2-4% of cases, the first or leading symptoms are hypertension and tachycardia (pheochromocytoma like symptoms) produced by catecholamines, norepinephrine, or dopamine excreted by the tumor.

• Other related symptoms include headache, perspiration, pallor, and nausea.

Page 41: Glomus Tumour

41

CLINICAL EXAMINATION

• Physical examination should include a complete inspection of the ears, nose, throat and neck.

• Cranial nerve function must be documented accurately.

• If the patient has visual symptoms, an ophthalmological opinion is essential.

Page 42: Glomus Tumour

42

• Careful otoscopic evaluation, preferably with an operating microscope, is essential.

• Classically, a red tumor mass beneath an intact tympanic membrane is seen – rising sun sign.

Page 43: Glomus Tumour

43

Page 44: Glomus Tumour

44

• If limited to the promontory with all tumor margins visible, it probably represents a small glomus tympanicum tumor.

• If the tumor extends beyond the level of the annulus (especially inferiorly), its classification cannot be made visually.

Page 45: Glomus Tumour

45

0toscopic stages

• Hypervascular stage – early stage. Dilatation of vessels of TM & EAC

• Tympanic stage – rising sun sign

• Polypoid or haemorrhagic stage – TM destroyed. Polypoidal bleeding mass in EAC.

Page 46: Glomus Tumour

46

The reddish mass filling the middle ear and pushing the tympanic membrane

Page 47: Glomus Tumour

47

• A small mass seen in the floor of the middle ear may represent the “tip of the iceberg” of a large glomus jugulare tumor that may extensively involve the skull base.

• These tumors may blanch with positive pressure on pneumotoscopy (Brown’s sign) or have cessation of tumor pulsation with ipsilateral carotid artery compression (Aquino’s sign).

Page 48: Glomus Tumour

48

• An audible bruit or evidence of vascular pulsations during tympanometry may also be present in these patients.

• A glomus tumor filling the middle ear may also cause a diffusely discolored appearance of the tympanic membrane, which may be mistaken for serous fluid.

Page 49: Glomus Tumour

05/02/2023

CLASSIFICATION

LUNDGREN CLASSIFICATIONGLASSCOCK- JACKSON CLASSIFICATIONFISCH CLASSIFICATIONGUILD HISTOLOGICAL CLASSIFICATIONMODIFIED DE LA CRUZ CLASSIFICATION

Page 50: Glomus Tumour

05/02/2023

LUNDGRENS CLASSIFICATION

Glomus Tympanicum

Glomus Jugulare

Page 51: Glomus Tumour

05/02/2023

GLASSCOCK-JACKSON CLASSIFICATION

GLOMUS TYMPANICUM :

Type I : Small tumor limited to Promontory.

Type II: Tumor completely filling Middle Ear Space.

Type III: Tumor filling middle ear & extending into Mastoid process.

Type IV: Tumor filling middle ear, extending into mastoid or through

tympanic membrane to fill external auditory canal, may extend anterior to

internal carotid artery

Page 52: Glomus Tumour

05/02/2023

• GLOMUS JUGULARE

Type I : Small tumor involving the jugular bulb, middle ear and mastoid.Type II: Tumor extending under the Internal Auditory Canal. There may be intracranial extension.Type III: Tumor extending into the Petrous Apex. There may be intracranial extension.Type IV: Tumor extending beyond the petrous apex into the clivus and Infratemporal Fossa. There may be intracranial extension.

Page 53: Glomus Tumour

05/02/2023

FISCH AND MATTOX CLASSIFICATION

Type A - Tumor limited to Middle Ear (carries the best

prognosis)

Type B - Tumor limited to the Tympanomastoid Area

with no infralabyrinthine compartment involvement

Page 54: Glomus Tumour

05/02/2023

• Type C - Tumor involving the Infralabyrinthine Compartment of temporal bone with extension to petrous apex Type C1 - Tumor with limited involvement of the vertical portion of the carotid canal Type C2 - Tumor invading the vertical portion of the carotid canal Type C3 - Tumor invasion of the horizontal portion of the carotid canal

Page 55: Glomus Tumour

05/02/2023

Type D - Tumor with Intracranial Extension

Type D1 - Tumor with an intracranial extension

less than 2 cm in diameter

Type D2 - Tumor with an intracranial extension

greater than 2 cm in diameter

Page 56: Glomus Tumour

56

De La Cruz Glomus Tumor Classification with Associated Surgical Approach

Classification Surgical Approach• Tympanic - Transcanal• Tympanomastoid - Mastoid• Jugular bulb – Mastoid / neck (possible limited facial nerve rerouting)• Carotid artery - Infratemporal fossa ± subtemporal or Transdural Infratemporal fossa/intracranial• Craniocervical - Transcondylar• Vagal - Cervical

Page 57: Glomus Tumour

Differential diagnosis• DIFFERENTIAL DIAGNOSIS Dehiscent jugular Bulb

Otitis Media

Otosclerosis

Cholesterol Granuloma

Aberrant Intrapetrous Internal Carotid Artery

Idiopathic Hemotympanum

Aneurysm

Arteriovenous Malformation

Persistent stapedial artery

Page 58: Glomus Tumour

58

Differential diagnoses also include

• Chordoma• Eosinophilic Granuloma

(Histiocytosis X)• Meningioma• Schwannoma• Neurofibroma• Chondrosarcoma• Carcinoma (primary and

metastatic)• Cholesteatoma

• Osteoma• Chronic mastoiditis• Lymphoma

Page 59: Glomus Tumour

05/02/2023

MANAGEMENT

Page 60: Glomus Tumour

60

INVESTIGATIONS

• Any attempt at biopsy should be deferred until a complete workup is done.

• A systematic protocol allows one to make the diagnosis and to define the extent of the tumor.

Page 61: Glomus Tumour

61

ENDOCRINOLOGICAL TESTING

• 1-3 percent of glomus tumours have the capacity to synthesize and secrete catecholamines- noradrenaline and dopamine.

• 24-hour urine collections for catecholamine metabolite assessment

• The level of vanillylmandelic acid (VMA) and metanephrine in a 24-hour urine sample may indicate neurosecretory activity

Page 62: Glomus Tumour

62

AUDIOLOGICAL EVALUATION

• Audiologic examination reveals mixed conductive and sensorineural hearing loss.

• The sensorineural component tends to be more significant with larger tumors.

Page 63: Glomus Tumour

63

X - RAY

• Plain skull radiography may show1) Enlargement of the lateral jugular foramen and fossa. 2)Clouding of mastoid air cells3)Bone destruction4)Phelp s sign – absence of normal crest of bone between carotid

canal and jugular fossa on lateral x- ray

Page 64: Glomus Tumour

64

C T SCAN

• High Resolution thin section CT SCAN(<1mm) in both axial and coronal plain is the imaging modality of choice

• A combination of CT scanning and contrast MRI is the imaging regimen of choice for glomus jugulare tumors.

Page 65: Glomus Tumour

65

C T shows

• Soft tissue mass in the tympanic cavity that may or may not erodes the jugular foramen• The ossicles may be displaced upwards.• Destruction of floor of tympanic cavity.

Page 66: Glomus Tumour

05/02/2023

• Enhance intensely with contrast• Erosion of normal crest of bone between carotid

canal and jugular fossa-Phelps sign• Moth eaten appearance due to destruction of

bony rim

Page 67: Glomus Tumour

67

CT imaging demonstrates the extent of bony destruction (white and black arrows) by the tumor. The normal jugular foramen on

the left (arrow head) is shown for comparison.

Page 68: Glomus Tumour

68

Page 69: Glomus Tumour

69

Magnetic resonance imaging (MRI)• Magnetic resonance imaging (MRI) with gadolinium-

diethylenetriamine pentaacetic acid (DTPA) contrast is best for delineating tumor limits.

• T1-Weighted images-intermediate intensity

• T2-Weighted images-Hyperintense with strong contrast enhancement.

Page 70: Glomus Tumour

05/02/2023

• Glomus tumors on T1- and T2-weighted MRI have characteristic soft tissue mixed intensity with intermixed high-intensity signals and signal voids -salt and pepper appearance representing fast flowing blood

Page 71: Glomus Tumour

71

T2-weighted axial MRI

• Salt and Pepper appearance of the tumour resulting from flow voids.

Page 72: Glomus Tumour

72

T1-weighted coronal slices

• It shows the involvement of the jugular bulb and the sigmoid-jugular complex (arrows).

Page 73: Glomus Tumour

73

• Special subtraction MRI sequences may help distinguish a glomus tympanicum tumor from a glomus jugulare tumor.

Page 74: Glomus Tumour

74

Arteriography• Unless carotid arteriography is necessary for preoperative

evaluation and/or embolization, noninvasive techniques are preferred

• For large tumors involving the internal carotid artery (ICA), preoperative carotid arteriography with cross-compression or trial balloon occlusion is recommended.

Page 75: Glomus Tumour

75

Angiographic Imaging

• Arrows delineate the tumor blush.

• The arrowhead demonstrates a branch of the middle meningeal artery providing blood supply to the tumor.

Page 76: Glomus Tumour

76

Common feeding vessels

• The main blood supply is via the ascending pharyngeal artery from the external carotid artery (ECA) and branches from the petrous portion of the internal carotid artery (ICA)

• Larger glomus jugulare tumors may also have blood supply from other branches of the ECA, ICA, vertebral artery, and thyrocervical trunk.

Page 77: Glomus Tumour

77

• After angiography, superselective embolization of the tumor-feeding vessels is performed at the same time.

• Performed 1-2 days before excision• Advantages- Decreased operative time

Decreased blood loss Complete resection

Page 78: Glomus Tumour

78

• During cerebral angiography, the patency of the venous drainage system of the opposite side and the patency of the cerebral cross flow are evaluated.

• For tumors with large intracranial extension, vertebral arteriography is advised to exclude arterial feeders from the posterior circulation.

Page 79: Glomus Tumour

79

MAGNETIC RESONANCE ARTERIOGRAPHY AND VENOGRAPHY

• Flow-sensitive weighting of the MRI can produce a magnetic resonance arteriography and magnetic resonance venography that are very useful in imaging glomus tympanicum lesions.

• The flow-sensitive modalities can indicate occlusion of the jugular bulb and vein, which can be particularly helpful for identifying involvement of the jugular bulb.

Page 80: Glomus Tumour

80

• A particular value of flow-weighted MRI is that it can be a useful screening test for synchronous paragangliomas.

• Provide information on relationship of tumour to great vessels.

Page 81: Glomus Tumour

81

Retrograde venography

• The venous drainage systems also need to be carefully studied before sinus occlusion is carried out during surgical resection.

• It also help to differentiate between glomus jugulare and glomus tympanicum.

• Glomus jugulare shows a filling defect.

Page 82: Glomus Tumour

82

OCTREOTIDE SCANNING

• I 123 Labelled Tyr 3 octreotide • Paragangliomas have type 2 receptors on cell surface

for somatostatin analogues• More sensitive(97%) and specific (82) for diagnosis• Localisation < 1cm• Detect recurrent lesion-Do not interfere with post

operative changes

Page 83: Glomus Tumour

83

PET SCAN

• Detect multiple site paraganglioma with SDHD and SDHB gene mutation• Patients with known metastatic disease• Sensitivity-100%

Page 84: Glomus Tumour

05/02/2023

GENETIC TESTING

• Recommended for patients with positive family history or multifocal disease.• Identification of mutation useful in –

Prognosis Predicting risk of malignancy

Page 85: Glomus Tumour

85

GLOMUS TUMOURSTreatment

Page 86: Glomus Tumour

86

• Treatment is palliative or definitive (curative). • Definitive treatment is surgical.• RT is considered a palliative therapy.

Page 87: Glomus Tumour

87

• No lesion is technically unresectable. • Each treatment plan is based on data generated by the

diagnostic evaluation• Must consider patient factors such as age, tumor

type,natural history, and general medical health.

Page 88: Glomus Tumour

88

• Palliation is reserved for the elderly, medically infirm,or those select, multicentric lesions in which definitive treatment is otherwise contraindicated.

Page 89: Glomus Tumour

89

• Radiation therapy can be used alone; however, it is usually

reserved for patients with concurrent medical problems or the elderly(65-75 years)who may be at higher risk for surgical complications.

Page 90: Glomus Tumour

90

SURGICAL MANAGEMENT

• One of the most challenging procedures in head and neck surgery.

Page 91: Glomus Tumour

91

BASIC PRINCIPLES• Exposure of all tumor margins• Identification/control of vital regional anatomy• Access to all margins of Intracranial Extention

Page 92: Glomus Tumour

92

• During surgery in the region of the jugular foramen, cranial nerves VII-XII are particularly vulnerable.

• Any damage to the seventh cranial nerve results in far more serious morbidity than impairment of one or more of the other cranial nerves.

• Continuous intraoperative facial nerve monitoring should be performed routinely.

Page 93: Glomus Tumour

93

• The facial nerve nearly always causes a major obstruction to the direct surgical access of the jugular foramen.

• Various surgical approaches have been described, all with the intention of preserving the anatomical integrity of the facial nerve in combination with adequate surgical exposure.

Page 94: Glomus Tumour

94

• The internal carotid artery is another major issue for concern.

• The vertical part of the carotid canal lies close to venous and nervous structures in the jugular foramen.

• Some lesions invade the petrous carotid artery, which makes preservation of this vessel problematic.

Page 95: Glomus Tumour

95

Preoperative embolization

• If surgical removal is indicated, some tumours should be previously embolized.

• Selective arteriography is performed 24 to 48 hours prior to surgery.

• Tumour is embolized via branches of the external carotid artery.

Page 96: Glomus Tumour

96

• Care is taken to embolize only those branches of the external carotid artery that are feeders to the tumour, in order to avoid neurological problems caused by reflux of embolic material into the intracranial circulation.

• There is general agreement that preoperative embolization significantly reduces blood loss during surgery and this facilitates complete removal of the tumour.

Page 97: Glomus Tumour

97

• Excessive bleeding can lead to incomplete tumour resection, damage to adjacent structures and post -operative morbidity.

• It is therefore sensible to assess their vascularity by angiography and undertake superselective embolization in selected cases.

Page 98: Glomus Tumour

98

Relevant anatomy of the area

• The walls of the jugular foramen are formed anterolaterally by the petrous bone and posteromedially by the occipital bone.

• The canal follows an anterior, inferior, and lateral direction to exit the skull.

• Glomus tumours usually arise in the lateral part of the jugular foramen

Page 99: Glomus Tumour

99

Page 100: Glomus Tumour

100

• The posterolateral portion of the foramen (pars venosa) contains the jugular bulb, posterior meningeal artery

• The anteromedial portion (pars nervosa) contains the inferior petrosal sinus and cranial nerve IX,X and XI, Superior ganglion of glossopharyngeal nerve and jugular ganglion of vagus nerve.

• The jugular bulb is situated between the sigmoid sinus and the internal jugular vein.

Page 101: Glomus Tumour

101

Page 102: Glomus Tumour

102

SURGICAL TECHNIQUE

Page 103: Glomus Tumour

103

Glomus TympanicumGLASSCOCK-JACKSON CLASSIFICATION• Type I : Small tumor limited to Promontory.

Type II: Tumor completely filling Middle Ear Space.Type III: Tumor filling middle ear & extending into Mastoid process. Type IV: Tumor filling middle ear, extending into mastoid or through tympanic membrane to fill external auditory canal, may extend anterior to internal carotid artery

Page 104: Glomus Tumour

104

• For a Class I tympanicum tumor - complete resection can be accomplished by means of a transcanal tympanotomy.

• The mass is avulsed from the promontory, and bleeding is

controlled by microbipolar coagulation or light packing.

Page 105: Glomus Tumour

105

Page 106: Glomus Tumour

106

• For a Class II - IV Glomus Tympanicum- a transmastoid approach /Extended facial recess is elected.

Page 107: Glomus Tumour

107

Extended facial recess approach

• In radiologically proven glomus tympanicum tumors whose borders are not entirely visible through the tympanic membrane, the extended facial recess approach is recommended.

Page 108: Glomus Tumour

108

• A cortical mastoidectomy is done.

• Facial nerve is identified and facial recess is opened via a diamond burr.

• Chorda tympani is identified and transected.

• The annulus is used as a lateral land mark to hypotympanum.

Page 109: Glomus Tumour

109

• Total tumor ressection done after exposing I C A and E T opening.

• Removal of retrofacial air cells provide complete exposure of hypotympanum.

• After tumor ressection middle ear is packed with gel foam.

Page 110: Glomus Tumour

110

Page 111: Glomus Tumour

111

• GLOMUS JUGULARE

Type I : Small tumor involving the jugular bulb, middle ear and mastoid.Type II: Tumor extending under the Internal Auditory Canal. There may be intracranial extension.Type III: Tumor extending into the Petrous Apex. There may be intracranial extension.Type IV: Tumor extending beyond the petrous apex into the clivus and Infratemporal Fossa. There may be intracranial extension.

Page 112: Glomus Tumour

112

• Glomus Jugulare Tumor Class I and II (Small to Medium)- Lateral Transtemporal surgical approach

Page 113: Glomus Tumour

113

Lateral Transtemporal surgical approach

• A wide retroauricular incision is made to gain access to the lateral aspect of the temporal bone .

• This incision is extended downwards into the neck to expose the structures in the infratemporal region.

Page 114: Glomus Tumour

114

Page 115: Glomus Tumour

115

• Wide cortical atticomastoidectomy is performed with skeletonization of the sigmoid sinus.

• A cranially based tympanomeatal flap can be developed for exposure of the hypotympanic region.

Page 116: Glomus Tumour

116

• After detachment of the tendon of the sternocleidomastoid muscle, the mastoid tip is removed.

• The mastoid segment of the fallopian canal is skeletonized, from the second genu towards the stylomastoid foramen.

Page 117: Glomus Tumour

117

• The bone anterior to this part of the facial nerve is removed and, at the same time, the dome of the jugular bulb is exposed.

• A diamond burr is used to remove as much bone as possible that covers the sigmoid sinus and the jugular bulb, so that the Fallopian bridge is the only structure that overlies the jugular bulb.

Page 118: Glomus Tumour

118

Page 119: Glomus Tumour

119

Page 120: Glomus Tumour

120

• As a result, the facial nerve may impair adequate exposure of lesions involving the jugular foramen, but the degree of access required also depends on the pathology

• In many cases, the vertical segment of the facial nerve has to be transposed, particularly if the lesions are extensive and bulky.

Page 121: Glomus Tumour

121

• The different approaches to facial nerve are as follows

Page 122: Glomus Tumour

122

CONSERVATIVE FACIAL NERVE MANAGEMENT

• Anatomical relationship between the mastoid segment of the facial nerve and the jugular bulb varies considerably.

• When the space between the two is small, it may be difficult to achieve adequate exposure.

Page 123: Glomus Tumour

123

• After the atticomastoidectomy, the sigmoid-jugular complex is exposed.

• The facial nerve is skeletonized and left in situ. • The sigmoid-jugular complex is controlled by sutures

around the sigmoid sinus and the internal jugular vein.

Page 124: Glomus Tumour

124

The right jugular foramen region is exposed without transposition of the facial nerve.

• 1, External auditory canal; 2, parotid gland;

• 3, glossopharyngeal nerve; 4, hypoglossal nerve;

• 5, internal carotid artery;• 6, vagus nerve;• 7, internal jugular vein;• 8, spinal accessory nerve; 9, jugular

bulb; • 10, facial nerve;• 11, sigmoid sinus;• 12, incus;• 13, semicircular canals.

Page 125: Glomus Tumour

125

• Some type of facial nerve transposition may need to be considered if visibility is poor and there is always the risk of incomplete tumour removal.

Page 126: Glomus Tumour

126

FACIAL NERVE TRANSPOSITION EAR, CANAL WALL UP

• This technique involves complete removal of the bony covering of the mastoid segment of the facial nerve, from the second genu down to the stylomastoid foramen.

• Outside the stylomastoid foramen, the nerve is followed and mobilized over its intraparotid course: first the main trunk and then the temporozygomatic and cervicofacial branches.

Page 127: Glomus Tumour

127

• The subdivisions of these branches are also mobilized and the overlying parotid tissue is removed.

• After this part of the procedure there is some mobility of the nerve, such that it can be pulled anteriorly, away from the jugular bulb.

Page 128: Glomus Tumour

128

The right jugular foramen region is exposed with a limited transposition of the facial nerve.

• After an atticomastoidectomy, the mastoid segment of the facial nerve is uncovered.

• The intraparotid part of the nerve is exposed and mobilized.

• The nerve can then be pulled anteriorly in order to provide access to the jugular bulb

Page 129: Glomus Tumour

129

FACIAL NERVE TRANSPOSITION EAR, CANAL WALL DOWN

• In order to be able to mobilize the facial nerve more extensively, atticomastoidectomy should be extended to subtotal petrosectomy.

• After a canal wall down atticomastoidectomy, the tympanic membrane, the malleus and the incus are removed.

Page 130: Glomus Tumour

130

• As a result, the facial nerve can be uncovered, not only in its mastoid segment, but also in its tympanic part.

• After mobilization of the intraparotid facial nerve, the nerve can be rerouted anteriorly.

• The hinge point (pivot) may be located at the second genu, but wider exposure is achieved when the nerve is displaced anteriorly with the hinge point at the first genu.

Page 131: Glomus Tumour

131

Facial nerve transposition canal wall down.

• The right jugular foramen region is exposed using a more extensive transposition of the 7th nerve.

• The facial nerve is uncovered in its mastoid and tympanic segments.

• The intraparotid part of the nerve is exposed and mobilized.

Page 132: Glomus Tumour

132

Facial nerve transposition, canal wall down.

• Maximum exposure of the right jugular foramen is achieved by rerouteing the facial nerve anteriorly with the hinge point at the first genu

Page 133: Glomus Tumour

133

MANAGEMENT OF THE SIGMOID-JUGULAR COMPLEX

• Damage to the sigmoid sinus or the jugular bulb is a serious risk during jugular foramen surgery.

• If the vessel wall is punctured, the initial bleeding is fairly simple to control, but retrograde haemorrhage from the internal jugular vein may follow.

Page 134: Glomus Tumour

134

• Therefore, the venous blood flow must be blocked at two levels: cranially and caudally to the lesion, i.e. upstream and downstream

• It is logical to start with blocking the main flow on the cranial side, the sigmoid sinus.

• Two methods have been described: ligating the vessel or packing it with Surgicel

Page 135: Glomus Tumour

135

Page 136: Glomus Tumour

136

• The upper neck can be explored by extending the retroauricular incision downwards.

• Internal jugular vein can be found easily in a later stage of the procedure, after the sternocleidomastoid muscle has been detached from the mastoid process and the mastoid tip has been removed.

Page 137: Glomus Tumour

137

• After identifying the surrounding structures, such as the internal carotid artery and the cranial nerves IX, X, XI and XII, the internal jugular vein should be ligated as high up as possible to avoid bleeding from veins that drain into it in the upper neck.

Page 138: Glomus Tumour

138

• The inferior and superior petrosal sinuses and the mastoid and condylar emissary veins drain into the sigmoid-jugular complex.

• Usually in a later stage of the procedure, the sigmoid sinus and the jugular bulb have to be opened to remove the tumour.

• Then bleeding can be expected from these sinuses and emissary veins, which should be dealt with by firm packing with Surgicel.

Page 139: Glomus Tumour

139

MANAGEMENT OF THE INTERNAL CAROTID ARTERY

• Damage to the internal carotid artery is likely to be followed by uncontrollable arterial haemorrhage.

• The tumour may be attached to the internal carotid artery or be in close contact with it.

Page 140: Glomus Tumour

140

• Visualization of the plane between the tumour and the petrous carotid artery is extremely important.

• Operative field should be as bloodless as possible.• All sources of venous haemorrhage must be meticulously

controlled, either by ligation or by packing with Surgicel.

Page 141: Glomus Tumour

141

• Glomus tumours may invade the carotid canal, first in its vertical part and eventually along the horizontal part on to the foramen lacerum.

• Glomus tumours may also receive part of their blood supply from the petrous carotid artery, e.g. via its caroticotympanic or dural branches.

Page 142: Glomus Tumour

142

• In very large tumours, permanent balloon occlusion of the internal carotid artery must be considered, but only if there is sufficient collateral circulation.

• It can be tested preoperatively during the angiography procedure by temporary occlusion.

Page 143: Glomus Tumour

143

• Extensive lesions and malignant tumours may require wide resection with sacrifice of the internal carotid artery.

• In these cases an extracranial-intracranial bypass procedure has to be considered

Page 144: Glomus Tumour

144

• Tulleken et al. described an extracranial-intracranial bypass technique that is considerably safer, because it precludes the ligation of intracranial vessels.

• In this method, first a venous graft or transplant is connected to the bifurcation of the carotid artery in the neck

Page 145: Glomus Tumour

145

• This transplant is connected end-to-side to the recipient posterior cerebral artery.

• Relatively safe alternative to permanent balloon occlusion.

Page 146: Glomus Tumour

146

(a) A platinum ring is attached to the outside of the recipient artery, at the bifurcation of the intracranial internal carotid artery.

Page 147: Glomus Tumour

147

(b) The end of a venous transplant is attached to the recipient artery and sutures around the platinum ring fix the recipient artery to the

donor.

Page 148: Glomus Tumour

148

• (c) A specially designed catheter with the excimer laser is introduced in the venous transplant.

Page 149: Glomus Tumour

149

• (d) The tip of the laser touches the wall of the artery.

• The platinum ring ensures proper positioning of the laser tip.

• This device has a circular configuration.• Laser fibres penetrate the recipient

artery after evaporization of the vessel wall.

Page 150: Glomus Tumour

150

• (e) The catheter is withdrawn along with a full-thickness portion of the recipient artery wall.

• A temporary clip is applied to the transplant.

• A conventional end-to-side anastomosis is made between the other end of the venous transplant and the external carotid artery in the neck.

• The bypass is functional after removal of the temporary clip.

Page 151: Glomus Tumour

151

• The sigmoid sinus and jugular bulb are opened to remove the tumour.

• After tumour resection, the cavity is filled with abdominal fat and covered with a pedicled temporalis muscle flap.

• Fibrin glue is also used routinely to prevent cerebrospinal fluid leakage.

Page 152: Glomus Tumour

152

• Lumbar drainage may be considered if the resection of a bulky tumour has left a voluminous cavity with wide access to the posterior fossa.

• Blind sac closure of the external ear canal is performed according to current standards.

Page 153: Glomus Tumour

153

• Glomus Jugulare Tumor Class III and IV (Medium to Large)- infratemporal fossa approach

Page 154: Glomus Tumour

154

The infratemporal fossa Approach• Fisch (1979) has excised lesions of the skull base and petrous

apex previously considered unresectable through the infratemporal fossa approach.

• The infratemporal fossa approach of Fisch (Fisch, 1977; Fisch and Pillsbury, 1979; Fisch et al, 1984) encompasses three distinct variations for use in specific clinical situations

Page 155: Glomus Tumour

155

• The type A approach provides exposure between the sigmoid sinus and the condylar fossa, designed to reach to the petrous apex and infralabyrinthine areas.

• It is most useful for management of cholesteatomas, meningiomas, and glomus tumors of those regions.

Page 156: Glomus Tumour

156

• The type B approach allows access from the sigmoid sinus to the petrous tip (including exposure of the horizontal ICA and foramen ovale) to reach lesions of the clivus, such as chordomas, meningiomas, glomus tumors and extensive apex cholesteatomas.

Page 157: Glomus Tumour

157

• The type C approach expands this access to include the parasellar region, the cavernous sinus, foramen rotundum, and foramen lacerum.

• Removal of the pterygoid plates in this approach also facilitates access to the nasopharynx.

• This type C approach is used in the resection of small nasopharyngeal carcinomas, adenoid cystic carcinomas, and angiofibromas

Page 158: Glomus Tumour

158

Procedure

• All three variations of the infratemporal fossa approach involve mastoidectomy, facial nerve dissection (and transposition), and obliteration of the eustachian tube, middle ear, and external auditory canal with resultant permanent conductive hearing deficit.

Page 159: Glomus Tumour

159

• It requires identification in the neck of the cranial nerves of the jugular foramen, transposition of the facial nerve, and removal of all the bone lateral to the tumor and jugular bulb.

• A wide mastoidectomy is performed, and the facial nerve is identified from the cochleariform process into the parotid gland and transposed anteriorly.

Page 160: Glomus Tumour
Page 161: Glomus Tumour

161

• The sigmoid sinus is packed off and opened, and the jugular vein is ligated and divided in the neck.

• The jugular vein is then elevated superiorly up to the jugular bulb, with care being taken to visualize and preserve the cranial nerves on its anteromedial surface.

Page 162: Glomus Tumour

162

• The tumor mass is then dissected free working the tumor margin in a circumferential fashion.

• As the tumor bleeds it is packed off with Surgicel, and a new area is dissected.

• Anteriorly, care must be taken to avoid injury to the carotid artery.

• Identification of the carotid artery remote from the tumor may be helpful in the development of this plane.

Page 163: Glomus Tumour

163

• Resection of posterior fossa dura, facial nerve, cochlea, and semicircular canals may be required in larger tumors.

• Any dural defects that exist are repaired.

• The surgical defect is packed with an abdominal fat graft.

Page 164: Glomus Tumour

164

• A subtotal petrosectomy anterior to the labyrinth exposes the entire intrapetrous course of the ICA.

• The facial nerve is transposed anteriorly for improved access.

• The petrous apex may be obliterated, the eustachian tube packed, and the external auditory canal closed laterally.

Page 165: Glomus Tumour
Page 166: Glomus Tumour
Page 167: Glomus Tumour
Page 168: Glomus Tumour

168

• The external auditory canal skin may be oversewn after removal of the deep external auditory canal skin.

• A conductive hearing loss, therefore, results.

• This approach has been reported in cases involving glomus tumors extending to the petrous apex.

Page 169: Glomus Tumour

169

Postoperative Details

• Careful monitoring of cardiac function is advisable-if a catecholamine secreting tumor was only partially resected.

• Postoperative lower cranial nerve deficits need to be carefully diagnosed -early rehabilitation is advocated

Page 170: Glomus Tumour

170

Complications of surgery:

• Death, cranial nerve palsies, bleeding, wound infection, cerebrospinal fluid (CSF) leak, meningitis, Stroke, Aspiration Pneumonia, uncontrollable hypotension/hypertension, Hearing loss and tumor regrowth.

Page 171: Glomus Tumour

171

NON SURGICAL MANAGEMENT

Page 172: Glomus Tumour

172

Wait and see policy

• In the pre-CT and MRI era, just the presence of a space-occupying lesion used to form sufficient grounds to proceed directly to surgery.

• Now a days, the size of a jugular foramen lesion can be accurately measured, monitored and documented with the available imaging modalities of CT and MRI.

Page 173: Glomus Tumour

173

• Most common lesions in the jugular foramen are frequently either slowly progressive or in a steady state.

• In many cases, the lesions do not pose a threat during the whole of the patient’s life.

Page 174: Glomus Tumour

174

• Slow growth and benign nature of majority of paragangliomas watchful waiting or observational may be considered for selected patients

• Elderly patients, Small tumours, Multiple comorbidities• Follow up imaging after 6 months and 12 months thereafter.

Page 175: Glomus Tumour

175

Radiotherapy • There is no consensus about whether conventional

fractionated radiotherapy is beneficial to patients with glomus tumours, because these tumours are histologically benign.

• The aim of radiotherapy for glomus tumours to destroy the microvascular tissue and bring about sclerosis

and fibrosis.

Page 176: Glomus Tumour

176

• Dose - 2000 to 3000 rads

• Advantage – pre op radiotherapy shrinks the tumor , decreases its vascularity.

• Disadvantage-damaging the surrounding structures, such as the cochlea, the facial nerve and adjacent brain tissue & cause radionecrosis of temporal bone.

Page 177: Glomus Tumour

177

• Radiotherapy for glomus tumours may also be an option in patients who refuse surgery, are elderly or have a poor physical condition.

Page 178: Glomus Tumour

178

Stereotactic radiosurgery

• Stereotactic radiosurgery is rapidly gaining popularity as a treatment modalIty.

• The term 'gamma knife stereotactic radiosurgery' describes the major components of the technique.

Page 179: Glomus Tumour

179

Systemic Therapy

• Malignant paraganglioma-palliative therapy• Reduce or stop the rate of growth• Combination of cyclophosphamide, vincristine, Dacabazine

and radionucleotide Iodine13I MIBG therapy• 5 year survival < 50%

Page 180: Glomus Tumour

180

Investigational Therapy

• Radiotherapy therapy with radiolabelled somatostatin analogues

• Sunitinib- Oral tyrosine kinase inhibitor prevent angiogenesis

Page 181: Glomus Tumour

181

Recurrence

• Glomus Tympanicum- <1%• Glomus Jugulare-5-10%

Page 182: Glomus Tumour

182

Follow-up

• GTy tumors yearly for 5 years and once every 5 years thereafter.

• Glomus jugulare-Because of their propensity for late recurrence and multicentricity,

postoperative MRI surveillance should be conducted 1year, 3 years, 5 years, and then every 5 years postoperatively for the life of the patient

Page 183: Glomus Tumour

183

THANK YOU

Page 184: Glomus Tumour

THANK YOU